Geode Capital Management
LEXX icon

Geode Capital Management’s Lexaria Bioscience LEXX Stock Holding History

Geode Capital Management’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140K Sell
16,694
-2,916
-15% -$31.6K ﹤0.01% 4026
2026
Q1 		$229K Buy
19,610
+4,962
+34% +$54K ﹤0.01% 3866
2025
Q4 		$136K Buy
14,648
+2,996
+26% +$42.5K ﹤0.01% 4023
2025
Q3 		$167K Hold
11,652
– – ﹤0.01% 3984
2025
Q2 		$152K Buy
11,652
+155
+1% +$2.67K ﹤0.01% 3955
2025
Q1 		$295K Buy
11,497
+385
+3% +$9.8K ﹤0.01% 3725
2024
Q4 		$350K Buy
11,112
+1,086
+11% +$40.1K ﹤0.01% 3710
2024
Q3 		$459K Buy
10,026
+2,374
+31% +$113K ﹤0.01% 3611
2024
Q2 		$319K Buy
7,652
+1,029
+16% +$46.3K ﹤0.01% 3739
2024
Q1 		$361K Buy
6,623
+3,050
+85% +$117K ﹤0.01% 3727
2023
Q4 		$67K Buy
3,573
+412
+13% +$7.96K ﹤0.01% 4282
2023
Q3 		$47K Sell
3,161
-95
-3% -$1.3K ﹤0.01% 4433
2023
Q2 		$35.3K Hold
3,256
– – ﹤0.01% 4577
2023
Q1 		$133K Hold
3,256
– – ﹤0.01% 4233
2022
Q4 		$119K Sell
3,256
-11
-0.3% -$395 ﹤0.01% 4330
2022
Q3 		$120K Sell
3,267
-61
-2% -$2.61K ﹤0.01% 4487
2022
Q2 		$148K Buy
3,328
+61
+2% +$2.45K ﹤0.01% 4419
2022
Q1 		$161K Hold
3,267
– – ﹤0.01% 4476
2021
Q4 		$198K Hold
3,267
– – ﹤0.01% 4472
2021
Q3 		$306K Sell
3,267
-92
-3% -$8.82K ﹤0.01% 4260
2021
Q2 		$352K Buy
+3,359
New +$300K ﹤0.01% 4095

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Geode Capital Management's LEXX Position: Q2 2026 in Review

Geode Capital Management reduced its Lexaria Bioscience (LEXX) stake by 15% in Q2 2026, selling an estimated $31.6K and leaving 16,694 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #4026.

Geode Capital Management first reported a position in LEXX in Q2 2021 and has held it in 21 quarters since. The position peaked at $459K in Q3 2024. 29 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

  • Geode Capital Management held 16,694 shares of Lexaria Bioscience worth $140K as of Q2 2026.
  • Geode Capital Management sold 2,916 Lexaria Bioscience shares in Q2 2026, an estimated $31.6K.
  • Lexaria Bioscience made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4026 holding.
  • Geode Capital Management first reported a position in Lexaria Bioscience in Q2 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Lexaria Bioscience position peaked at $459K in Q3 2024.
  • 29 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.